Ifinatamab structure
|
Common Name | Ifinatamab | ||
|---|---|---|---|---|
| CAS Number | 2484870-90-6 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of IfinatamabIfinatamab is monoclonal immunoglobulin G1-kappa with anti-human B7 homolog 3 protein (Human B7-H3). Ifinatamab is a glycoforme α immunomodulateur[1]. |
| Name | Ifinatamab |
|---|
| Description | Ifinatamab is monoclonal immunoglobulin G1-kappa with anti-human B7 homolog 3 protein (Human B7-H3). Ifinatamab is a glycoforme α immunomodulateur[1]. |
|---|---|
| Related Catalog | |
| References |
[1]. WHO Drug Information. International Nonproprietary Names for Pharmaceutical. |
| No Any Chemical & Physical Properties |